The utility of pharmacogenetic testing to support the treatment of bipolar disorder
Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3ASST S...
Saved in:
Main Authors: | Ielmini M (Author), Poloni N (Author), Caselli I (Author), Espadaler J (Author), Tuson M (Author), Grecchi A (Author), Callegari C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies
by: Silvia Vilches, et al.
Published: (2019) -
The North Italian innovative project for common psychiatric disorders: Evaluating the output of a treatment model of an outpatient clinic for anxiety and depression
by: Ivano Caselli, et al.
Published: (2023) -
Lithium treatment for bipolar disorder
by: Philip B. Mitchell, et al.
Published: (2000) -
The basic principals of pharmacogenetics testing in cancer treatment
by: Cikota-Aleksić Bojana M., et al.
Published: (2020) -
Pharmacogenetics in Primary Headache Disorders
by: Irina I. Belyaeva, et al.
Published: (2022)